A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Conditions: Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Stomach Neoplasms; Pancreatic Ductal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Small Cell Lung Carcinoma Interventions: Drug: SGN-CEACAM5C Sponsors: Seagen Inc.; Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials